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Abstract
Background: Inpatient HIV/AIDS charges decreased from 1996–2000. This decrease was mainly
attributable to treatment of HIV/AIDS patients with Highly Active Antiretroviral Therapy
(HAART). This study aims to evaluate the trend in inpatient charges from 2000–2004.
Methods:  Rhode Island Hospital Discharge Data (HDD) from 2000 to 2004 was used.
International Classification of Disease (ICD-9) diagnosis code 042–044 was used to identify HIV/
AIDS admissions. The final study population included 1927 HIV/AIDS discharges. We used a
multivariable linear regression model to examine the factors associated with inflation adjusted
inpatient charges.
Results: We found a significant increase in inpatient charges from 2000–2004 after adjusting for
length of stay (LOS), gender, age, race and point of entry for hospitalization. In addition to calendar
year, LOS, gender and race were also associated with inpatient charges.
Conclusion: HIV/AIDS inpatient charges increased after adjusting for inflation despite earlier
studies that showed a decline. Our results have implications for uninsured, as well as insured HIV/
AIDS patients who do not have a medical plan that covers their charges sufficiently. Future research
should investigate what factors are contributing to rising inpatient charges among HIV/AIDS
patients.
Background
Recent statistics show that an estimated 623,435 individ-
uals in the United States (US) are living with HIV[1]. HIV/
AIDS continues to be a major financial burden on the
health care system in the US[2]. The average annual HIV/
AIDS charges per patient were estimated to be approxi-
mately $18,000 from 1996–2000. Studies estimate that
around 50% of these average annual charges were attrib-
utable to inpatient care [2-4]. Inpatient charges for HIV/
AIDS patients are comparable to charges from other
chronic diseases. Reed et al. estimated that average annual
inpatient charges for intracerebral hemorrhage (ICH)
were $10,241[5]. The majority of charges for health serv-
ices among individuals infected with HIV/AIDS come
from public sources such as Medicaid, Ryan White, and
Medicare, making it imperative for those who allocate
health care dollars for HIV treatment to be aware of the
cost of treating people with HIV/AIDS [6]. In 1996, com-
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bination antiretroviral drug therapy became more com-
mon[7]. The average annual number of admissions and
charges for inpatient and overall HIV/AIDS care decreased
between 1996–2000 [8,9]. This decrease was mainly
attributable to Highly Active Antiretroviral Therapy
(HAART), which enabled many HIV/AIDS patients to be
treated on an outpatient basis, leading to an overall
decrease in inpatient length of stay (LOS) and inpatient
HIV/AIDS charges per person [9,10]. This decline in HIV/
AIDS charges was in sharp contrast to the increase in
charges that Hellinger had forecasted from 1989–1995
[11-13]. However, these forecasts were made prior to the
advent of HAART. Studies suggest that an estimated 20–
30% of HIV/AIDS patients are uninsured [14,15] making
it essential to continue to examine the burden of annual
HIV/AIDS charges to determine what is impacting HIV/
AIDS charges and how to decrease these charges.
The purpose of his study was to describe trends in inpa-
tient charges in Rhode Island between 2000 and 2004 for
hospital discharges where HIV/AIDS was the primary rea-
son for admission. In addition, socioeconomic demo-
graphic and clinical variations in inpatient hospital
charges among these discharges were examined.
Methods
Study Population
The Rhode Island Department of Health's Center for
Health Data and Analysis collects Hospital Discharge
Data (HDD) each year on inpatients from all 13 licensed
acute care hospitals and the rehabilitation facility in
Rhode Island from 2000–2004. The data reported to the
Department of Health includes information on demo-
graphic data, clinical items, and hospital charges[16]. The
data were restricted to the years 2000 to 2004, to dis-
charges with specific ICD 9 codes, and to a patient popu-
lation aged 18+. Because the file did not include a unique
medical identifier, it was not possible to distinguish
between patients with a single admission during the study
period versus multiple admissions. The final study popu-
lation included 1927 HIV/AIDS discharges. International
Classification of Disease (ICD-9) diagnosis code 042–044
was used to identify HIV/AIDS admissions. We decided to
include diagnoses that were not primary (> 50%) based
on the need to decrease the large amount of false negatives
that would result by excluding secondary and tertiary
diagnoses of HIV/AIDS. The Rhode Island HDD is a pub-
lic use file. We obtained consent to use this data from the
Rhode Island Department of Health.
Outcome Measure
Inpatient charges (in dollars) were measured as the total
charges of an admission to the hospital. Inpatient charges
do not include professional fees, and non-covered
charges. Non-covered charges are charges that patients or
insurance providers are not required to pay. Emergency
department charges incurred prior to admission are
included in total charges. Inpatient charges were adjusted
for inflation. Charges for subsequent years were deflated
to 2000 dollars. This was done by taking into account the
average annual percent growth in National Health Expen-
ditures. This measure estimates the amount spent on all
health services, supplies, health-related research, and con-
struction activities in the United States during the calen-
dar year.
Covariates
The independent variables included, LOS, and point of
entry for hospitalization. LOS was measured in days.
Point of entry for hospitalization had two categories:
Emergency Room, and patients who were referred to the
hospital through a physician, hospital clinic referral, or a
facility referral. Specific data on income, education, and
other components of SES were not available in the HDD
data. Therefore, we utilized the point of entry for hospital-
ization variable as a proxy for socioeconomic status (SES).
Previous studies have shown that patients referred
through the emergency room are of lower SES when com-
pared to patients with other types of hospital referrals
(physician, clinic, or facility) [17,18]. The demographic
variables included in this study were age, race, and gender.
Age was a continuous variable that was measured in years.
Race category consisted of six categories: white, black, His-
panic, Asian, unknown and other.
Statistical Analysis
Rhode Island HDD data from 2000–2004 were analyzed
using the Statistical Analysis System (SAS, version 9.1; SAS
Institute, Cary, NC). We performed a descriptive analysis
of demographic and clinical characteristics by year, using
one-way Analysis of Variance (ANOVA) and two-sample t-
tests for continuous outcomes and Pearson's chi-square
test of independence or Fisher's exact test for categorical
outcomes. Fisher's exact test replaced Pearson's chi-square
test when the expected cell count was less than 5 for a par-
ticular descriptive analysis. We used histograms and the
Kolmogorov-Smirnov test to determine if inpatient
charges and LOS followed a normal distribution. Due to
the skewness of the data a natural log transformation was
taken for LOS and inpatient charges. ANOVAs and t-tests
were performed on the log transformed data which was
subsequently back-transformed to generate the geometric
means and standard errors for LOS and inpatient charges.
Geometric means and standard deviations reported are
likely to be smaller than normal calculations involving
untransformed data. The reason for this is that the natural
log transformation reduces the influence of extreme
observations and outliers resulting in exponentiated geo-
metric values that inherit the reduced influence of extreme
observations. We used 2 multivariable linear regressionBMC Health Services Research 2009, 9:3 http://www.biomedcentral.com/1472-6963/9/3
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models to compare the coefficients for different years
across the models to understand how they change when
LOS is controlled. The 2 models examined factors associ-
ated with inflation adjusted inpatient charges, with LOS
excluded from the first model and included in the second
model. Comparing the 2 models enabled us to examine
how LOS mediates the effects of sociodemographic and
clinical variables. The inflation adjusted inpatient charges
were used as the outcome variable. The other independent
variables in these models included year, age, race, gender,
and point of entry for hospitalization. To meet the
assumption of normality of the linear regression model,
we performed a natural log transformation for inpatient
charges and LOS. Regression coefficients were then expo-
nentiated to obtain the estimated mean percentage
increase in inpatient charges for each independent varia-
ble. We used a test of linear trend to examine if certain fac-
tors are related to each other linearly. All tests were two-
sided with a type I error (α) of 0.05. The Bonferroni
adjustment of α/k (k number of comparisons) for post-
hoc ANOVA analysis was used to address the multiple
comparisons problem.
Results
Among HIV/AIDS discharges with a primary diagnosis in
Rhode Island from 2000–2004, 66.6% were male, 44.5%
were white, 36.8% were black and 13.5% were Hispanic.
The mean age of patients was approximately 42.7 ± 9.0
years. An estimated three quarters of the patients were
admitted through the emergency room and the geometric
mean for LOS was 4.7 ± 2.4 days. The inflation adjusted
geometric mean inpatient charges over the 5 year time
period was $11,480 ± 2.9.
Univariate Analyses
Inflation adjusted inpatient charges differed by point of
entry for hospitalization in 2001, and gender from 2002–
2004 (Table 1). In 2001, patients that were admitted
through an emergency room ($9,760 ± 3.9) had signifi-
cantly higher inpatient charges than patients who were
admitted by physician, clinic, or facility referral ($7,663 ±
2.6). Males had significantly higher inpatient charges than
women in 2002 ($12,544 ± 2.8 versus $9,404 ± 2.4), 2003
($16,652 ± 2.7 versus $14,561 ± 2.4), and 2004 ($18,966
± 3.0 versus $14,815 ± 2.7).
The test of trend showed a significantly increasing trend
for inpatient charges among HIV/AIDS admissions from
2000–2004 (Table 2). Average charges per HIV/AIDS
admission was least in 2000 ($8,771 ± 4.6) and greatest in
2004 ($17,367 ± 2.9). The greatest one-year increase in
charges (35.6%) and LOS (12.8%) occurred from 2003–
2004. LOS was found to be significantly higher in 2004
compared to 2001 (p = 0.001), after adjusting for multiple
comparisons by using a Bonferroni adjustment. Age, race,
LOS and inpatient charges differed significantly by year.
However, the test of trend showed that LOS did not have
a significantly increasing linear trend from 2000–2004.
Multivariable Analyses
In both multivariable models inpatient charges signifi-
cantly increased over time based on the test of trend after
adjusting for LOS, calendar year gender age, race and
point of entry for hospitalization (Table 3, 4). In the first
model that excluded LOS, inflation adjusted log inpatient
charges were significantly higher in 2002 (31%), 2003
(49%), and 2004 (101%) compared to 2000. Males had a
Table 1: Inpatient Charges among HIV/AIDS patients in Rhode Island per year, 2000–2004.
2000 (N = 402)
Mean ± SE
2001 (N = 396)
Mean ± SE
2002 (N = 343)
Mean ± SE
2003 (N = 416)
Mean ± SE
2004 (N = 370)
Mean ± SE
Gender
Male 8708 ± 1.06 8732 ± 1.1 12544* ± 1.07 16652* ± 1.07 18966* ± 1.07
Female 8641 ± 1.09 10044 ± 1.06 9404 ± 1.09 14561 ± 1.08 14815 ± 1.09
Race
Hispanic 7859 ± 1.14 9710 ± 1.18 11452 ± 1.13 10217 ± 1.16 18391 ± 1.15
Black 8869 ± 1.09 9254 ± 1.09 9943 ± 1.09 13162 ± 1.08 14197 ± 1.10
White 8901 ± 1.08 9121 ± 1.08 12729 ± 1.09 13307 ± 1.08 18035 ± 1.09
Asian 8698 ± 2.02 9142 ± 1.70 14600 ± 1.45 N/A N/A
Other 8435 ± 1.24 11129 ± 1.42 14379 ± 1.31 9055 ± 1.46 28529 ± 1.48
Unknown 6557 ± 1.77 2796 ± 1.83 N/A 10715 ± 1.51 20758 ± 1.34
Point of entry for Hospitalization
PCFa 8104 ± 1.09 7663* ± 1.10 12068 ± 1.12 13837 ± 1.2 17793 ± 1.12
ERb 8900 ± 1.06 9760 ± 1.06 11231 ± 1.06 12530 ± 1.06 17204 ± 1.07
Note: Geometric means and standard errors are presented in the table.
a Physician, Clinical, or Facility.
b Emergency Room.
*P < 0.05
†Point of entry for hospitalization is missing 1 observation in 2003.
N/A: Not applicable if there are no observations.BMC Health Services Research 2009, 9:3 http://www.biomedcentral.com/1472-6963/9/3
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Table 2: Demographic and Clinical Characteristics of HIV/AIDS patients by Year in Rhode Island, 2000–2004
2000
N (%)
Mean ± SE
2001
N (%)
Mean ± SE
2002
N (%)
Mean ± SE
2003
N (%)
Mean ± SE
2004
N (%)
Mean ± SE
Inpatient Charges†,* 8771 ± 1.05 9182 ± 1.05 11428 ± 1.06 12802 ± 1.05 17367 ± 1.05
LOS* 4.6 ± 1.05 4.3 ± 1.05 4.7 ± 1.05 4.7 ± 1.04 5.3 ± 1.05
Gender
Male 264 (65.7) 285 (72.0) 232 (67.6) 267 (64.2) 236 (63.8)
Female 138 (34.3) 111 (28.0) 111 (32.4) 149 (35.8) 134 (36.2)
Age* 42.9 ± 1.57 41.7 ± 1.57 42.9 ± 1.63 42.9 ± 1.56 43.2 ± 1.60
Race*
Hispanic 58 (14.4) 39 (9.8) 63 (18.4) 44 (16.9) 57 (15.4)
Black 133 (33.1) 134 (33.8) 139 (40.5) 175 (42.1) 129 (34.9)
White 185 (46.0) 207 (52.3) 120 (35.0) 183 (44.0) 163 (44.0)
Asian 2 (0.5) 4 (1.0) 7 (2.0) 1 (0.2) 1 (0.3)
Other 21 (5.2) 9 (2.3) 13 (3.8) 7 (1.7) 7 (1.9)
Unknown 3 (0.8) 3 (0.8) 1 (0.3) 6 (1.4) 13 (3.5)
Point of entry for Hospitalization
PCFa 105 (26.1) 100 (25.2) 83 (24.2) 99 (23.9) 97 (26.2)
ERb 297 (73.9) 296 (74.8) 260 (75.8) 316 (76.1) 273 (73.8)
Note: Geometric means and standard errors are presented in the table.
a Physician, Clinical, or Facility.
b Emergency Room.
*P < 0.05
†P for linear trend < 0.05.
‡Point of entry for hospitalization is missing 1 observation in 2003.
Table 3: Relationship of Demographic and Clinical Characteristics to Inpatient Charges among HIV/AIDS Patients in Rhode Island 
excluding LOS, 2000–2004.
Estimated Increase in Inpatient Charges Adjusted % 95% CI
Year†
2000 --
2001 3- 1 0  t o  1 9
2002* 31 13 to 52
2003* 49 29 to 71
2004* 101 74 to 133
Agea -0.5 -1 to 0
Gender
Female --
Male* 17 6 to 29
Race
White --
Black -8 -17 to 2
Hispanic 16 -32 to 95
Asian -6 -19 to 8
Other 27 -4 to 67
Unknown -6 -38 to 41
Point of entry for Hospitalization
PCFb --
ERc 3- 1 2  t o  2 5
a Age in 1 year increments, are modeled as continuous covariates.
b Physician, Clinical, or Facility.
c Emergency Room.
*P < 0.05
†P for linear trend < 0.05.BMC Health Services Research 2009, 9:3 http://www.biomedcentral.com/1472-6963/9/3
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17% (95% CI, 6–29) significant mean increase in inpa-
tient charges than females. This model (R2 = 0.0646)
accounted for only 6.46% of the variance in log inpatient
charges. This small R2 is primarily due to not having LOS
in the model.
In the model that included LOS, compared to 2000, inpa-
tient charges increased significantly in 2001 (11%), 2002
(31%), 2003 (45%) and 2004 (73%) respectively. LOS
and other race were also found to be significantly associ-
ated with log inpatient charges in this model. For each 1
day increase in LOS, inpatient charges increased on aver-
age by 166% (95% CI, 159–173) after adjusting for other
factors. Admissions that belonged to the other race cate-
gory had a 19% (95% CI, 3.3–37.5) mean increase in
inpatient charges compared to whites. Inpatient charges
were significantly lower among blacks (-11%, 95% CI, -
16.8,-6.4) and Asians (-11%, 95% CI, -17.8,-4.5) com-
pared to whites. Males had a 10% (95% CI, 4.6–15.9)
increase in inpatient charges compared to females in this
model. The results of the multivariable model generated a
R2  of 0.7473, showing that our model accounted for
74.73% of the variance in log inpatient charges.
Discussion
This study found that mean inflation adjusted inpatient
charges for HIV/AIDS patients in Rhode Island increased
significantly from 2000 to 2004, after adjusting for LOS,
gender, age, race, and point of entry of hospitalization.
This increase in inpatient charges followed a significantly
increasing linear trend from 2000–2004. These results
indicate that HIV/AIDS charges are increasing at a faster
than inflation. The variable LOS helped explain most of
the variance in HIV/AIDS inpatient charges. Males had
significantly higher inpatient charges than females in both
multivariable models. Race was also a significant predic-
tor of inpatient charges in the multivariable model that
included LOS. However, this result was likely due to the
few observations in the other race category. Some admis-
sions in the other race category had higher than expected
inpatient charges most likely enabling this finding to
occur.
Our findings are in contrast to the findings of studies con-
ducted in the late 1990's, when HAART treatment led to a
decrease in inpatient HIV/AIDS charges [2,19,20]. Despite
the consistent increase in inpatient charges from 2000–
2004, LOS was only significantly higher in 2004 com-
pared to 2001. This suggests that there are other factors
that are influencing the increase in HIV/AIDS inpatient
charges.
In addition to calendar year and LOS, race, and gender
influenced inpatient HIV/AIDS charges. Contrary to other
Table 4: Relationship of Demographic and Clinical Characteristics to Inpatient Costs among HIV/AIDS Patients in Rhode Island, 2000–
2004
Estimated Increase in Inpatient Costs Adjusted % 95% CI
Year†
2000 --
2001* 11 3.5 to 20.1
2002* 31 21.3 to 41.6
2003* 45 35.0 to 56.3
2004* 73 60.7 to 87.0
LOSa, * 166 159.0 to 173.2
Agea -2 -4.5 to 0.8
Gender
Female --
Male* 10 4.6 to 15.9
Race
White --
Black* -11 -16.8 to -6.4
Hispanic -17 -37.2 to 8.4
Asian* -11 -17.8 to -4.5
Other* 19 3.3 to 37.5
Unknown 7 -28.3 to 9.8
Point of entry for Hospitalization
PCFb --
ERc 2 -0.4 to 7.4
a LOS in 1 day increments, Age in 1 year increments, are modeled as continuous covariates.
b Physician, Clinical, or Facility
c Emergency Room
*P < 0.05
†P for linear trend < 0.05BMC Health Services Research 2009, 9:3 http://www.biomedcentral.com/1472-6963/9/3
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studies, we found that blacks and Asians had significantly
lower inpatient charges than whites[8,21]. Also, contrary
to Gebo et al. this study did not find that females had sig-
nificantly higher inpatient charges than men[8].
This study, like most studies, has limitations. The data we
examined cannot account for multiple admissions. It is
likely that there were multiple admissions by a single
patient. Secondly, Rhode Island Hospital Discharge Data
does not contain information on other key factors that are
known to influence HIV/AIDS charges. For example, we
are unable to determine the proportion of the HIV/AIDS
charges that were attributable to medications, co-morbid-
ities, physician charges, and other factors that may influ-
ence charges. We were unable to determine how inpatient
charges differed by insurance status. This variable was
excluded from the analyses based on the fact that more
than 25% of the sample had missing insurance informa-
tion. Another potential limitation is that a proportion of
the uninsured HIV/AIDS admissions that were admitted
may have decided to not receive hospital care due to lack
of finances and thus they would not have the normal LOS
and inpatient charges as others. Also, we are unable to
attribute what percentage of these inpatient charges were
due to other conditions that patients may have been
treated for in addition to HIV/AIDS. Lastly, our results are
not generalizable beyond Rhode Island. Based on this lack
of generalizability we are unable to make inferences for
the entire US based on our results.
Despite these limitations our study has important impli-
cations for uninsured, as well as insured HIV/AIDS
patients whose health care plan does not cover HIV/AIDS
treatment adequately. As stated earlier a large portion of
HIV/AIDS patients in the US are uninsured. Many of these
individuals are of low SES and cannot afford to purchase
an adequate health care plan. The increase in HIV/AIDS
inpatient charges makes it more difficult for many of these
individuals to pay for their treatment, resulting in lack of
treatment options which can negatively impact morbidity
and mortality rates.
Conclusion
Charges for inpatient HIV/AIDS services seem to be rising
faster than inflation. Our results suggest that LOS is asso-
ciated with an increase in inpatient charges from 2000–
2004 in Rhode Island however the level of LOS does not
seem to fully account for this increase. Other factors seem
to also be influencing this increase in inpatient charges
over time. It is possible that charges for medical tests and
procedures are increasing however we are unable to exam-
ine these variables due to the limitations of our data.
Future research should focus on obtaining informative
clinical data on these medical factors in order to deter-
mine their influence on inpatient charges over time. Also,
it is essential to examine if these findings are consistent in
the other parts of the US.
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